List of articles in "Drug" category - Page 185

LY-272015 is a beta-carboline derivative drug developed by Eli Lilly which acts as a potent and selective antagonist at the serotonin 5-HT2B receptor. It has anti-hypertensive effects in animal models […]

BW-723C86 is a tryptamine derivative drug which acts as a 5-HT2B receptor agonist.

RS-102221 is a drug developed by Hoffmann–La Roche which was one of the first compounds discovered that acts as a potent and selective antagonist at the serotonin 5-HT2C receptor with […]

SB-204741 is a drug which acts as a potent and selective antagonist at the serotonin 5-HT2B receptor with around 135x selectivity over the closely related 5-HT2C receptor and even higher […]

RS-127445 is a drug which acts as a potent and selective antagonist at the serotonin 5-HT2B receptor with around 1000x selectivity over the closely related 5-HT2A and 5-HT2C receptors. The […]

NmVac4-A/C/Y/W-135 is the commercial name of the Meningococcal meningitis polysaccharide serogroups ACY and W-135 vaccine of JN-International Medical Corporation. The product is specially designed and formulated to be used in […]

The drug combination sulfacetamide/sulfur is a topical acne medication manufactured by Medicis under the trade name Plexion and also available under other trade names such as Clenia Prascion and Avar. […]

Tasimelteon (trade name Hetlioz previously known as BMS-214778) is a drug approved solely for the treatment of non-24-hour sleep–wake disorder in totally blind people. It was under development for the […]

Alazocine ((-)-SKF-10047) or (-)-N-allylnormetazocine ((-)-ANMC) was the first drug discovered to act as a σ1 receptor agonist (Ki = 24 nM). It has no significant affinity for the σ2 receptor. […]

Neratinib (HKI-272) is a tyrosine kinase inhibitor under investigation for the treatment breast cancer and other solid tumours.It is in development for the treatment of early- and late-stage HER2-positive breast […]